Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 53 entries
View as:

Taxoprexin® Treatment for Advanced Eye Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00244816 Org: User:
Start: 10/31/05 End: 04/30/07 Due: 04/30/08

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02492672 Org: User:
Start: 09/30/14 End: 12/31/18 Due: 12/31/19

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00396292 Org: User:
Start: 02/28/05 End: 02/28/06 Due: 02/28/07

A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA

Phase: N/A Priority: Normal
NCT ID: NCT02410213 Org: User:
Start: 02/19/15 End: 06/01/17 Due: 06/01/18

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00703937 Org: User:
Start: 07/31/08 End: 03/31/11 Due: 03/31/12

Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01984554 Org: User:
Start: 09/30/13 End: 12/31/14 Due: 12/31/15

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00317226 Org: User:
Start: 06/30/05 End: 09/30/07 Due: 09/30/08

Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures

Phase: N/A Priority: Normal
NCT ID: NCT01819610 Org: User:
Start: 02/28/13 End: 08/31/14 Due: 08/31/15

Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT01351090 Org: User:
Start: - End: 10/31/07 Due: 10/31/08

Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study

Phase: N/A Priority: Normal
NCT ID: NCT03037931 Org: User:
Start: 03/15/17 End: 02/02/23 Due: 02/02/24

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00243867 Org: User:
Start: 11/30/05 End: 08/31/08 Due: 08/31/09

Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron

Phase: N/A Priority: Normal
NCT ID: NCT01950247 Org: User:
Start: 08/15/13 End: 06/30/15 Due: 06/30/16

Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00704353 Org: User:
Start: 06/30/08 End: 03/31/11 Due: 03/31/12

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00422877 Org: User:
Start: 01/31/07 End: 03/31/08 Due: 03/31/09

Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00740246 Org: User:
Start: 07/31/05 End: 05/31/06 Due: 05/31/07

Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

Phase: N/A Priority: Normal
NCT ID: NCT00982007 Org: User:
Start: 09/30/09 End: 08/31/11 Due: 08/31/12

Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00981045 Org: User:
Start: 08/31/09 End: 08/31/11 Due: 08/31/12

Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT06690450 Org: User:
Start: 08/31/01 End: 02/28/02 Due: 02/28/03

Intravenous Iron Metabolism in Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00685815 Org: User:
Start: 11/30/06 End: 12/31/12 Due: 12/31/13

Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza

Phase: N/A Priority: Normal
NCT ID: NCT01290302 Org: User:
Start: 11/22/10 End: 12/21/12 Due: 12/21/13

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00236951 Org: User:
Start: 02/28/03 End: 12/31/05 Due: 12/31/06

Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety

Phase: N/A Priority: Normal
NCT ID: NCT05661682 Org: User:
Start: 02/01/25 End: 12/04/26 Due: 12/04/27

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

Phase: N/A Priority: Normal
NCT ID: NCT02086968 Org: User:
Start: 01/01/14 End: 10/31/17 Due: 10/31/18

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00395993 Org: User:
Start: 05/31/05 End: 06/30/06 Due: 06/30/07

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00236964 Org: User:
Start: 02/23/01 End: 05/30/02 Due: 05/30/03